These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6235834)

  • 1. Oral spironolactone improves acne vulgaris and reduces sebum excretion.
    Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P
    Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of topical spironolactone on sebum excretion.
    Walton S; Cunliffe WJ; Lookingbill P; Keczkes K
    Br J Dermatol; 1986 Feb; 114(2):261-4. PubMed ID: 2936373
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical benzoyl peroxide increases the sebum excretion rate in patients with acne.
    Cunliffe WJ; Stainton C; Forster RA
    Br J Dermatol; 1983 Nov; 109(5):577-9. PubMed ID: 6227330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral spironolactone: an effective treatment for acne vulgaris in women.
    Muhlemann MF; Carter GD; Cream JJ; Wise P
    Br J Dermatol; 1986 Aug; 115(2):227-32. PubMed ID: 2943311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population.
    King K; Jones DH; Daltrey DC; Cunliffe WJ
    Br J Dermatol; 1982 Nov; 107(5):583-90. PubMed ID: 6215056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone and cimetidine in treatment of acne.
    Hatwal A; Bhatt RP; Agrawal JK; Singh G; Bajpai HS
    Acta Derm Venereol; 1988; 68(1):84-7. PubMed ID: 2449021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone therapy in hirsutism and acne.
    Callan AW
    Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
    [No Abstract]   [Full Text] [Related]  

  • 10. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progesterone on sebum excretion rate.
    Simpson NB; Dick D; Hodgins MB
    Br J Dermatol; 1979 Jun; 100(6):735. PubMed ID: 157154
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
    Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
    Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
    Poinas A; Lemoigne M; Le Naour S; Nguyen JM; Schirr-Bonnans S; Riche VP; Vrignaud F; Machet L; Claudel JP; Leccia MT; Hainaut E; Beneton N; Dert C; Boisrobert A; Flet L; Chiffoleau A; Corvec S; Khammari A; Dréno B
    Trials; 2020 Jun; 21(1):571. PubMed ID: 32586344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of topically applied progesterone on sebum excretion rate.
    Simpson NB; Bowden PE; Forster RA; Cunliffe WJ
    Br J Dermatol; 1979 Jun; 100(6):687-92. PubMed ID: 157150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of propranolol on acne vulgaris and the rate of sebum excretion.
    Cunliffe WJ; Cotterill J
    Br J Dermatol; 1970 Nov; 83(5):550-1. PubMed ID: 4249553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of topical retinoid therapy on seborrhea using iontophoresis].
    Knor T
    Med Arh; 2003; 57(5-6):295-8. PubMed ID: 15022582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone in adolescent acne vulgaris.
    Dhurat R; Shukla D; Lim RK; Wambier CG; Goren A
    Dermatol Ther; 2021 Jan; 34(1):e14680. PubMed ID: 33326148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormones and acne: pathophysiology, clinical evaluation, and therapies.
    Thiboutot D
    Semin Cutan Med Surg; 2001 Sep; 20(3):144-53. PubMed ID: 11594669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sebum excretion rate and biochemistry in patients with acne vulgaris treated by oral fenfluramine.
    Cotterill JA; Cunliffe WJ; Williamson B
    Br J Dermatol; 1971 Aug; 85(2):127-9. PubMed ID: 4255130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.